MeSH D012220 - rhinitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Pseudoephedrine, Triprolidine | Triphed | 1984-05-17 | |||
| Pseudoephedrine, Triprolidine | Triprolidine Pseudoephedrine | 1984-12-12 | ||||
| Taro Pharmaceutical | Oxymetazoline | Oxymetazoline | 2021-10-04 | |||
| Xiromed | Ephedrine | Ephedrine | 2022-04-21 | |||
| Johnson & Johnson | Oxymetazoline | Visine | 1989-03-31 | |||
| GSK | Triprolidine | Actidil | 1983-07-01 | |||
| Pseudoephedrine, Codeine, Triprolidine | Actifed | 1984-04-04 | ||||
| Sandoz | Ephedrine | Ephedrine | 2017-08-23 | |||
| Pseudoephedrine, Triprolidine | Pseudoephedrine Triprolidine | 1983-05-17 | ||||
| Novartis | Chlorpheniramine, Phenylpropanolamine | Triaminic | 1982-01-01 | |||
| Alpharma | Hydrocodone, Phenylpropanolamine | Codamine | 2000-09-29 | |||
| Triprolidine | Triprolidine | 1982-01-01 | ||||
| Allergan | Triprolidine | Triprolidine | 1982-01-01 | |||
| Pseudoephedrine, Triprolidine | Triprolidine Pseudoephedrine | 1984-01-13 |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
100%7/7
Phase 2
57%8/14
Phase 3
41%13/32
Approved: 5Overall Success rate: 23%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use